Search

everythinglearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Sebum helps protect human skin from microbes.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

Syntaxin 9 helps in transporting and signaling of the EGF receptor in skin and stomach cells.

Vitamin D helps skin stem cells heal wounds by working with a key skin protein.

PADI4 enzyme slows down cell growth in developing hair follicles.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

XEDAR triggers a specific signaling pathway in cells.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The document's conclusion cannot be provided because the content is not accessible.

GD-23 reduces anxiety by relying on neurosteroid production.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

Trichothiodystrophy is a condition with brittle hair and various physical and mental issues due to low sulfur in proteins.

Tmem50b and 2610305D13Rik genes play key roles in early mouse embryo development.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Low ERCC3 gene activity is linked to non-pigmented hair growth.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.